Institutional investors purchased a net $28.3 thousand shares of NVGN during the quarter ended December 2015 and now own 1.54% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 22.3 Thousand shares of Novogen Ltd
UBS SECURITIES LLC Bought 4.8 Thousand shares of Novogen Ltd
CITIGROUP GLOBAL MARKETS, INC. (... Sold 77.00 shares of Novogen Ltd